Sarah K. Browne

Infectious Disease
10903 New Hampshire Ave
Silver Spring, MD 20993

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.

Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.

Journal: Lancet (London, England)
Published: September 05, 2025

Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.

Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.

Journal: JHEP reports : innovation in hepatology
Published: November 12, 2024

Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.

Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.

Journal: The New England journal of medicine
Published: March 20, 2024

Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study.

Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study.

Journal: Journal of hepatology
Published: February 01, 2024

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.

Journal: Vaccine
Published: June 19, 2019

Severe Facial Herpes Vegetans and Viremia in NFKB2-Deficient Common Variable Immunodeficiency.

Severe Facial Herpes Vegetans and Viremia in NFKB2-Deficient Common Variable Immunodeficiency.

Journal: Frontiers in pediatrics
Published: December 02, 2018

Clinical features of Sjögren's syndrome patients with autoantibodies against interferons.

Clinical features of Sjögren's syndrome patients with autoantibodies against interferons.

Journal: Clinical and translational medicine
Published: September 25, 2018

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Journal: The Journal of clinical investigation
Published: November 02, 2016

Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Journal: JCI insight
Published: September 03, 2016

Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.

Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 16, 2016

Reply to Tham et al.

Reply to Tham et al.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 03, 2016

Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.

Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 08, 2015
Showing 1-12 of 37

Last Updated: 09/26/2026